Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis

被引:31
作者
Fyhr, IM
Moslemi, AR
Mosavi, AA
Lindberg, C
Tarkowski, A
Oldfors, A
机构
[1] GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT PATHOL,S-41345 GOTHENBURG,SWEDEN
[2] GOTHENBURG UNIV,DEPT RHEUMATOL,S-41345 GOTHENBURG,SWEDEN
[3] GOTHENBURG UNIV,DEPT NEUROL,S-41345 GOTHENBURG,SWEDEN
关键词
inclusion body myositis; T cell receptor; oligoclonal expansion; V beta 3 and V beta 8; complementarity determining region 3;
D O I
10.1016/S0165-5728(97)00122-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inclusion body myositis (IBM) is the most common muscle disease affecting individuals over 50 years of age. An important feature of IBM is invasion of muscle fibers by T cells. The muscle infiltrating T cells show a restricted usage of variable (V) alpha/beta gene families. In this study we have investigated the clonality of T cells using two of the predominant VP families i.e. V beta 3 and V beta 8 in three patients with IBM. The study was performed by reverse transcription and polymerase chain reaction (RT-PCR) analysis, followed by cloning and sequencing of the T cell receptor complementarity determining region 3. We found oligoclonal expansion of V beta 3 bearing muscle infiltrating T cells in two patients and of V beta 8 in one patient, supporting the concept that antigen stimulated T cells are important in the pathogenesis of IBM. Results of HLA typing indicated a genetic predisposition for the disease by the presence of DR3, DR52 and DQB 1*0201/0202 in all three patients. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:185 / 189
页数:5
相关论文
共 24 条
[1]   MONOCLONAL-ANTIBODY ANALYSIS OF MONONUCLEAR-CELLS IN MYOPATHIES .4. CELL-MEDIATED CYTO-TOXICITY AND MUSCLE-FIBER NECROSIS [J].
ARAHATA, K ;
ENGEL, AG .
ANNALS OF NEUROLOGY, 1988, 23 (02) :168-173
[2]  
Askanas Valerie, 1993, Current Opinion in Rheumatology, V5, P732
[3]  
Askanas Valerie, 1995, Current Opinion in Rheumatology, V7, P486, DOI 10.1097/00002281-199511000-00005
[4]   POLYMYOSITIS, DERMATOMYOSITIS, AND INCLUSION-BODY MYOSITIS [J].
DALAKAS, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1487-1498
[5]   T-CELL RECEPTOR PEPTIDE IMMUNIZATION LEADS TO ENHANCED AND CHRONIC EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
DESQUENNECLARK, L ;
ESCH, TR ;
OTVOS, L ;
HEBERKATZ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7219-7223
[6]   T-CELL REPERTOIRES IN HEALTHY AND DISEASED HUMAN TISSUES ANALYZED BY T-CELL RECEPTOR BETA-CHAIN CDR3 SIZE DETERMINATION - EVIDENCE FOR OLIGOCLONAL EXPANSIONS IN TUMORS AND INFLAMMATORY DISEASES [J].
EVEN, J ;
LIM, A ;
PUISIEUX, I ;
FERRADINI, L ;
DIETRICH, PY ;
TOUBERT, A ;
HERCEND, T ;
TRIEBEL, F ;
PANNETIER, C ;
KOURILSKY, P .
RESEARCH IN IMMUNOLOGY, 1995, 146 (02) :65-80
[7]   Limited T-cell receptor V gene usage in inclusion body myositis [J].
Fyhr, IM ;
Moslemi, AR ;
Tarkowski, A ;
Lindberg, C ;
Oldfors, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (01) :109-114
[8]  
GAMBETTI P, 1995, AM J PATHOL, V145, P1261
[9]  
GARLEPP MJ, 1994, CLIN EXP IMMUNOL, V98, P40
[10]   INCLUSION-BODY MYOSITIS AND MYOPATHIES [J].
GRIGGS, RC ;
ASKANAS, V ;
DIMAURO, S ;
ENGEL, A ;
KARPATI, G ;
MENDELL, JR ;
ROWLAND, LP .
ANNALS OF NEUROLOGY, 1995, 38 (05) :705-713